Quest Diagnostics (DGX) Total Liabilities (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Total Liabilities data on file, last reported at $9.0 billion in Q1 2026.

• Quarterly Total Liabilities rose 1.95% year-over-year to $9.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.0 billion (up 1.95% YoY) and the FY2025 annual result came in at $9.1 billion, down 3.05% from the prior year.
• Total Liabilities fell to $9.0 billion in Q1 2026 per DGX's latest filing, from $9.1 billion in the prior quarter.
• The five-year high for Total Liabilities was $9.3 billion in Q4 2024, with the low at $6.7 billion in Q1 2023.
• Average Total Liabilities over 5 years is $7.9 billion, with a median of $7.5 billion recorded in 2024.
• Year-over-year, Total Liabilities fell 4.57% in 2023 and soared 31.84% in 2024.
• Quest Diagnostics' Total Liabilities stood at $6.9 billion in 2022, then advanced by 11.19% to $7.7 billion in 2023, then increased by 21.61% to $9.3 billion in 2024, then fell by 3.05% to $9.1 billion in 2025, then slipped by 0.53% to $9.0 billion in 2026.
• Business Quant data shows DGX's Total Liabilities at $9.0 billion in Q1 2026, $9.1 billion in Q4 2025, and $8.9 billion in Q3 2025.